Rhythm Pharmaceuticals, Inc. IPO Research Information

Rhythm Pharmaceuticals, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Rhythm Pharmaceuticals, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Rhythm Pharmaceuticals, Inc.	RYTM - NASDAQ	$14.00-$16.00	$17.00	$23.21	7.05 million	10/5/2017
Underwriter(s): Morgan Stanley, BofA Merrill Lynch, Cowen & Co.
Co-Manager(s): Needham & Co.
Industry: Health Care
Filing(s): 1st Filed 2014-08-27 Filed 2017-09-05 Terms Added 2017-09-25

Rhythm Pharmaceuticals, Inc. Quote & Chart - Click for current quote - RYTM

About Rhythm Pharmaceuticals, Inc. (adapted from Rhythm Pharmaceuticals, Inc. prospectus):
They are a biopharmaceutical company focused on the development and commercialization of peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders.

This description is adapted from Rhythm RYTM prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Rhythm RYTM "RYTM" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.